Who is speaking

Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.

If you have a cutting edge case study or a presentation and would like to join the speaker panel at one of our events, please contact Jenny Clark at j.clark@oxfordglobal.co.uk

2015 Speakers

  • Yasmina Abdiche
    Research Fellow, Pfizer
  • Dina Anderson
    Senior Principal Scientist, Research Project Management, Syntaxin LTD, an Ipsen Company
  • Caroline Barelle
    CEO/CSO, Elasmogen Ltd
  • Andreas Baumann
    Director and Principal Scientific Expert Biologics, Bayer
  • Pierre-François Berne
    Head of Antibody Display, Sanofi
  • Stanislas Blein
    Director and Head Antibody Engineering, Biologics Research, Glenmark Pharmaceuticals
  • Daryl Drummond
    Vice President, Discovery, Merrimack Pharmaceuticals
  • Jacques Dumas
    Head, Protein Biotherapeutics, Sanofi
  • James Errey
    Director, Biomolecular Structure, Heptares Therapeutics
  • Laurence Fayadet-Dilman
    Director, Protein Sciences, Merck
  • Joachim Feldwisch
    Director, Preclinical Development, Affibody
  • Nicolas Fischer
    Head of Research, NovImmune
  • Ernesto Friere
    Professor, John Hopkins University
  • Stefan Geschwindner
    Principal Scientist, AstraZeneca
  • Steffen Hartmann
    Global Head Protein Developability, Novartis
  • Alistair Henry
    Director, Structural Biology and Biophysics, UCB
  • Guy Hermans
    Research Fellow, Ablynx
  • Rob Howes
    Associate Director, HTS, Antibody Discovery and Protein Engineering, MedImmune
  • Roman Kischel
    Principal Scientist, Amgen
  • Will Lewis
    Head of Purification Research, GSK
  • Laura Lin
    Director, Biophysics, Analytics and Bioconjugation, Pfizer
  • Lorenz Mayr
    Vice President, Global Head Reagents and Assay Development, AstraZeneca
  • Mark McAlistair
    Associate Director, Structure & Biophysics, Astrazeneca
  • Brian McGuinness
    VP Discovery, Crescendo Biologics
  • Werner Meier
    Vice President, Biologics Drug Discovery, Biogen Idec
  • Muthu Meiyappan
    Associate Director, Head of Analytical, Discovery Therapeutics, Shire
  • Ralph Minter
    Fellow, Antibody Discovery and Protein Engineering, MedImmune
  • Herbert Nar
    Director, Structural Research, Boehringer Ingelheim
  • Ray Owens
    Professor, Oxford University and Head, OPPF-UK
  • David Pearlman
    Senior Principal Scientist, Schrödinger Inc.
  • Andrew Popplewell
    Director, V-Region Discovery and Engineering, UCB
  • Matthew Sleeman
    Senior Director of Biology, Respiratory, Inflammation and Autoimmunity, MedImmune
  • Marco Thomann
    Manager, Development Analytics, Roche
  • John Thompson
    Consultant to Aldevron Freiburg GmbH
  • Gino van Heeke
    Senior Research Fellow, Ablynx
  • Annelise Vuidepot
    Head of Protein Science, Immunocore
  • Robert Wilkinson
    Director, Oncology, MedImmune
  • Stefan Zahn
    Principal Scientist, Novo Nordisk
MRC.jpgAIMM.jpgChelatec.jpgAgilent copy.jpgSGS.jpgIBIS.jpgShire.jpgPfizer 2.jpgGlenbervie.jpgAffibody.jpgNovozymes.jpgSanger.jpgMetanomics.jpg